You are here:

Enfuvirtide (Fuzeon®)


Recommended for restricted use within NHS Scotland.


Restricted to use by clinicians experienced in the management of HIV infected patients. It is licensed for use in combination with other antiretroviral medicinal products for the treatment of HIV-1 infected patients who have received treatment with and failed on regimens containing at least one medicinal product from each of the following antiretroviral classes, protease inhibitors, non-nucleoside reverse transcriptase inhibitors and nucleoside reverse transcriptase inhibitors, or who have intolerance to previous antiretroviral regimens.

Drug Details

Drug Name: Enfuvirtide (Fuzeon®)
SMC Drug ID: 56/03
Manufacturer: Roche
Indication: HIV
BNF Category:
Sub Category: 5.3 Antiviral Drugs
Submission Type: Full submission
Status: Restricted
Date Advice Published: 11 August 2003